查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612028

美容注射市场：按产品、性别、应用和最终用户划分 - 全球预测 2025-2030

Aesthetic Injectables Market by Product (Anti-aging Injections, Dermal Fillers), Gender (Female, Male), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年註射美容市场价值为110.8亿美元，预计到2024年将达到119.5亿美元，复合年增长率为7.85%，到2030年将达到188.1亿美元。

美容注射包括真皮填充剂和肉毒毒素，旨在恢復年轻外观并增强脸部特征。这些产品解决了各种美容问题，包括减少皱纹、丰唇和脸部轮廓。由于产品配方的进步和不断增长的老龄化人口寻求美学改善的推动，对非手术、微创美容疗程的需求日益增长，这强调了美容注射的需求。使用时，可涂抹于额头、鱼尾纹、脸颊、嘴唇和下巴等脸部区域。主要的最终使用者是美容诊所、皮肤科中心、医院，有时还有牙科诊所。市场驱动因素包括可支配收入的增加、社交媒体影响下美容趋势的放大以及美容护理意识的提高。此外，男性消费者的兴趣不断增加，市场进一步扩大。然而，其局限性包括潜在的副作用、某些地区缺乏训练有素的专业人员以及治疗费用高昂。此外，严格的法律规范为市场成长带来了重大挑战，特别是在产品核可和安全合规方面。为了利用潜在的机会，公司应该专注于扩大产品适应症以涵盖治疗应用，以及创新产品配方以确保提高耐用性和增强可模仿特性。探索生物分解性的替代品和个人化注射剂可能会开创针对性美容疗程的新时代。此外，扩大我们在化妆品支出不断增加的新兴市场的地域影响力可以开闢新的业务途径。在技​​术创新方面，人工智慧咨询将为每位患者制定个人化的治疗计划，从而有可能提高患者满意度。市场动态是动态的，主要由消费者情绪和新的美容标准驱动，需要不断适应和创新以保持竞争优势。公司需要跟上技术进步和监管变化，以有效利用市场机会。

主要市场统计
基准年[2023] 110.8亿美元
预计年份 [2024] 119.5亿美元
预测年份 [2030] 188.1亿美元
复合年增长率（%） 7.85%

市场动态：揭示快速发展的美容注射市场的关键市场洞察

供需的动态交互作用正在改变美容注射市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于美容趋势和人口老化，美容注射的使用增加
    • 水疗中心和美容院的增加
    • 政府和卫生当局改革以推广美容疗程选择
  • 市场限制因素
    • 美容注射和产品召回的高成本
  • 市场机会
    • 美容注射工具和方法的持续创新
    • 创业投资对美容注射新兴企业的投资
  • 市场挑战
    • 与美容注射相关的健康风险

波特五力：驾驭美容注射市场的策略工具

波特的五力框架是了解美容注射市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对美容注射市场的影响

外部宏观环境因素对美容注射市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解美容注射市场竞争状况

美容注射市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位基质化妆品注射剂市场供应商的绩效评估

FPNV定位矩阵是评估注射美容市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製美容注射市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，美容注射市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于美容趋势和人口老化，美容注射的使用正在增加。
      • 水疗中心和美容院的增加
      • 政府和卫生当局改革以推广美容疗程选择
    • 抑制因素
      • 美容注射和产品召回的高成本
    • 机会
      • 美容注射工具和方法的不断创新
      • 创业投资对美容注射新兴企业的投资
    • 任务
      • 与美容注射相关的健康风险
  • 市场区隔分析
    • 类型：增加使用抗衰老注射来减少皱纹
    • 最终使用者：皮肤科诊所提供各种美容治疗，因此美容注射很容易取得。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章美容注射市场：副产品

  • 抗衰老注射
    • A型肉毒桿菌毒素
    • 聚左旋乳酸（PLLA）微粒
  • 真皮填充剂
    • 胶原蛋白填充剂
    • 玻尿酸
    • 合成填料

第七章美容注射市场性别

  • 女士
  • 男人

第八章美容注射市场：依应用分类

  • 痤疮疤痕治疗
  • 拉皮
  • 脸部线条矫正
  • 丰唇术
  • 脂肪萎缩的治疗

第九章美容注射市场：依最终用户分类

  • 美容诊所
  • 皮肤科诊所
  • 皮肤科研究所
  • 医疗水疗

第十章 北美、南美注射美容市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太美容注射市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲美容注射市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Cynosure与Lutronic合併，成为全球医学美容技术领导者
    • Galderma推出新的AR工具「FACE by Galderma」以视觉化注射治疗结果
    • FDA核准美国新型玻尿酸注射「SKINVIVE by JUVEDERM」 平滑脸颊
  • 战略分析和建议

公司名单

  • Adoderm GmbH
  • Allergan, Inc. by AbbVie Inc.
  • Anika Therapeutics, Inc.
  • Bio Plus Co., Ltd.
  • Bioxis Pharmaceuticals
  • Bloomage Biotechnology Corp., Ltd.
  • Bohus Biotech AB
  • Croma-Pharma GmbH
  • Cutera, Inc.
  • Cynosure, LLC
  • Dr. Korman Laboratories Ltd.
  • Galderma SA
  • Hugel America, Inc.
  • Ipsen Pharma
  • Laboratoires Vivacy, SAS
  • MedyTox Inc.
  • Merz Pharma GmbH & Co.KGaA
  • Prollenium Medical Technologies Inc.
  • Revance Therapeutics, Inc.
  • SciVision Biotech Inc.
  • Sinclair Pharma Ltd
  • Suneva Medical, Inc.
  • Teoxane SA
  • USWM, LLC
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-6702BB6513EA

The Aesthetic Injectables Market was valued at USD 11.08 billion in 2023, expected to reach USD 11.95 billion in 2024, and is projected to grow at a CAGR of 7.85%, to USD 18.81 billion by 2030.

Aesthetic injectables, encompassing dermal fillers and botulinum toxins, aim to restore a youthful appearance and enhance facial features. These products address various aesthetic concerns, including wrinkle reduction, lip augmentation, and facial contouring. The growing desire for non-surgical and minimally invasive cosmetic treatments, fueled by advancements in product formulations and an increasing aging population seeking aesthetic improvements, underscores the necessity for aesthetic injectables. Application-wise, these can be administered to facial areas like the forehead, crow's feet, cheeks, lips, and jawline. The primary end-users include cosmetic clinics, dermatology centers, hospitals, and at times, dental practices. Market insights reveal key growth drivers such as rising disposable incomes, social media influence amplifying beauty trends, and heightened awareness of aesthetic treatment availability. Additionally, male consumer interest is growing, further expanding the market. However, limitations include potential side effects, a lack of trained professionals in certain regions, and the premium cost of treatments. Moreover, stringent regulatory frameworks pose significant challenges to market growth, especially regarding product approval and safety compliance. To leverage potential opportunities, companies should focus on innovation in product formulations ensuring enhanced durability and mimetic enhancement, alongside expanding product indications to encompass therapeutic uses. Research into biodegradable alternatives and personalized injectables could usher in a new era of targeted cosmetic therapies. Additionally, expanding geographic presence in emerging markets with increasing cosmetic spending could provide new business avenues. On the innovation front, AI-driven consultations can allow for personalized treatment plans, improving patient satisfaction. The aesthetic injectables market is dynamic and primarily driven by consumer sentiments and emerging beauty standards, necessitating continuous adaptation and innovation to maintain competitive advantage. Businesses should stay abreast of technological advances and regulatory changes to effectively capitalize on market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 11.08 billion
Estimated Year [2024] USD 11.95 billion
Forecast Year [2030] USD 18.81 billion
CAGR (%) 7.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aesthetic Injectables Market

The Aesthetic Injectables Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising usage of aesthetic injections due to beauty trends and aging population
    • Increasing number of spa and beauty salons
    • Government and health authority reforms that promote aesthetic treatment options
  • Market Restraints
    • High cost of aesthetic injectables and product recalls
  • Market Opportunities
    • Ongoing innovations in the tools and methods used for administering aesthetic injectables
    • Venture capital investments into aesthetic injectable start-ups
  • Market Challenges
    • Health risks associated with aesthetic injectables

Porter's Five Forces: A Strategic Tool for Navigating the Aesthetic Injectables Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aesthetic Injectables Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aesthetic Injectables Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aesthetic Injectables Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aesthetic Injectables Market

A detailed market share analysis in the Aesthetic Injectables Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aesthetic Injectables Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aesthetic Injectables Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aesthetic Injectables Market

A strategic analysis of the Aesthetic Injectables Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aesthetic Injectables Market, highlighting leading vendors and their innovative profiles. These include Adoderm GmbH, Allergan, Inc. by AbbVie Inc., Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp., Ltd., Bohus Biotech AB, Croma-Pharma GmbH, Cutera, Inc., Cynosure, LLC, Dr. Korman Laboratories Ltd., Galderma SA, Hugel America, Inc., Ipsen Pharma, Laboratoires Vivacy, S.A.S., MedyTox Inc., Merz Pharma GmbH & Co.KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., SciVision Biotech Inc., Sinclair Pharma Ltd, Suneva Medical, Inc., Teoxane SA, USWM, LLC, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Aesthetic Injectables Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Anti-aging Injections and Dermal Fillers. The Anti-aging Injections is further studied across Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Micro Particles. The Dermal Fillers is further studied across Collagen Fillers, Hyaluronic Acid, and Synthetic Fillers.
  • Based on Gender, market is studied across Female and Male.
  • Based on Application, market is studied across Acne Scar Treatment, Face Lift, Facial Line Correction, Lip Augmentation, and Lipoatrophy Treatment.
  • Based on End User, market is studied across Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes, and Medical Spa.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising usage of aesthetic injections due to beauty trends and aging population
      • 5.1.1.2. Increasing number of spa and beauty salons
      • 5.1.1.3. Government and health authority reforms that promote aesthetic treatment options
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of aesthetic injectables and product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations in the tools and methods used for administering aesthetic injectables
      • 5.1.3.2. Venture capital investments into aesthetic injectable start-ups
    • 5.1.4. Challenges
      • 5.1.4.1. Health risks associated with aesthetic injectables
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of anti-aging injections to reduce the appearance of wrinkles
    • 5.2.2. End User: High accessibility of aesthetic injectables by dermatology clinics as they provide several cosmetic treatments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aesthetic Injectables Market, by Product

  • 6.1. Introduction
  • 6.2. Anti-aging Injections
    • 6.2.1. Botulinum Toxin A
    • 6.2.2. Poly-L-Lactic Acid (PLLA) Micro Particles
  • 6.3. Dermal Fillers
    • 6.3.1. Collagen Fillers
    • 6.3.2. Hyaluronic Acid
    • 6.3.3. Synthetic Fillers

7. Aesthetic Injectables Market, by Gender

  • 7.1. Introduction
  • 7.2. Female
  • 7.3. Male

8. Aesthetic Injectables Market, by Application

  • 8.1. Introduction
  • 8.2. Acne Scar Treatment
  • 8.3. Face Lift
  • 8.4. Facial Line Correction
  • 8.5. Lip Augmentation
  • 8.6. Lipoatrophy Treatment

9. Aesthetic Injectables Market, by End User

  • 9.1. Introduction
  • 9.2. Beauty Clinics
  • 9.3. Dermatology Clinics
  • 9.4. Dermatology Research Institutes
  • 9.5. Medical Spa

10. Americas Aesthetic Injectables Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Aesthetic Injectables Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Aesthetic Injectables Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Cynosure and Lutronic Merge to Form Global Leader in Medical Aesthetic Technology
    • 13.3.2. Galderma Launches FACE by Galderma, a New AR Tool Helps Visualize Injectable Treatment Results
    • 13.3.3. FDA Approves SKINVIVE by JUVEDERM, a new U.S. Hyaluronic Acid Injection for Smoother Cheeks
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adoderm GmbH
  • 2. Allergan, Inc. by AbbVie Inc.
  • 3. Anika Therapeutics, Inc.
  • 4. Bio Plus Co., Ltd.
  • 5. Bioxis Pharmaceuticals
  • 6. Bloomage Biotechnology Corp., Ltd.
  • 7. Bohus Biotech AB
  • 8. Croma-Pharma GmbH
  • 9. Cutera, Inc.
  • 10. Cynosure, LLC
  • 11. Dr. Korman Laboratories Ltd.
  • 12. Galderma SA
  • 13. Hugel America, Inc.
  • 14. Ipsen Pharma
  • 15. Laboratoires Vivacy, S.A.S.
  • 16. MedyTox Inc.
  • 17. Merz Pharma GmbH & Co.KGaA
  • 18. Prollenium Medical Technologies Inc.
  • 19. Revance Therapeutics, Inc.
  • 20. SciVision Biotech Inc.
  • 21. Sinclair Pharma Ltd
  • 22. Suneva Medical, Inc.
  • 23. Teoxane SA
  • 24. USWM, LLC
  • 25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. AESTHETIC INJECTABLES MARKET RESEARCH PROCESS
  • FIGURE 2. AESTHETIC INJECTABLES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AESTHETIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AESTHETIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AESTHETIC INJECTABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AESTHETIC INJECTABLES MARKET DYNAMICS
  • TABLE 7. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ACNE SCAR TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACE LIFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY LIP AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY LIPOATROPHY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MEDICAL SPA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. AESTHETIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. AESTHETIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023